Aleksandra Antovic

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.

Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.

Journal: Scandinavian journal of rheumatology

Published: May 22, 2026

Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden.

Occurrence of venous thromboembolism in SLE: findings from a nationwide cohort and a clinical cohort in Sweden.

Journal: Lupus science & medicine

Published: March 22, 2026

The risk of venous thromboembolism in RA.

The risk of venous thromboembolism in RA.

Journal: Rheumatology (Oxford, England)

Published: January 31, 2026

Second delivery rates and recurrence of adverse pregnancy outcomes in women with systemic lupus erythematosus: a nationwide population-based cohort study.

Second delivery rates and recurrence of adverse pregnancy outcomes in women with systemic lupus erythematosus: a nationwide population-based cohort study.

Journal: Rheumatology (Oxford, England)

Published: December 15, 2025

Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Journal: RMD open

Published: October 26, 2025

Vascular events in autoantibody-defined clusters of SLE: a 12-year prospective cohort study.

Vascular events in autoantibody-defined clusters of SLE: a 12-year prospective cohort study.

Journal: Rheumatology (Oxford, England)

Published: April 22, 2025

Circulating extracellular vesicles as predictive biomarkers of progressive interstitial lung disease in systemic sclerosis-a prospective cohort study.

Circulating extracellular vesicles as predictive biomarkers of progressive interstitial lung disease in systemic sclerosis-a prospective cohort study.

Journal: Frontiers in medicine

Published: March 15, 2025

Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome-A Single-Centre Cohort Study.

Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome-A Single-Centre Cohort Study.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: February 22, 2025

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey.

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey.

Journal: Therapeutic advances in musculoskeletal disease

Published: December 18, 2024

Association of C4d with disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis: evidence for classical/lectin complement pathway activation.

Association of C4d with disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis: evidence for classical/lectin complement pathway activation.

Journal: Arthritis research & therapy

Published: November 25, 2024

Urinary TWEAK reflects disease activity in ANCA-associated vasculitis.

Urinary TWEAK reflects disease activity in ANCA-associated vasculitis.

Journal: Clinical kidney journal

Published: September 12, 2024

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.

Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study.

Journal: RMD open

Published: August 05, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026